1B anticoagulant therapy Flashcards
What are some therapeutic indications for anticoagulation?
-
Venous thrombosis
- Initial treatment to minimise clot extension/embolisation (< 3 months)
- Long term treatment to reduce risk of recurrence
-
Atrial fibrillation
- 800 per 100 000 population potentially eligible in 1 year
- To reduce risk of embolic stroke
- Mechanical prosthetic heart valve
What are preventative indications for anticoagulation (thromboprophylaxis)?
e.g. Following surgery, during hospital admission, during pregnancy
What is heparin?
- Naturally occurring glycosaminoglycan
- Produced by mast cells of most species
- Porcine products used in UK
Describe the lengths of heparin chains
Varying number of saccharides in chains: differing lengths:
- Long chains: unfractionated (UFH)
- IV administration
- short half-life
- Low molecular weight (LMWH): subcutaneous administration
What does unfractionated heparin do?
Enhancement of antithrombin
- Inactivation of thrombin (Hep binds AT + thrombin)
- Inactivation of FXa (Hep binds AT only)
- Inactivation of FIXa, FXIa, FXIIa)
What does LMWH do?
- Contain pentasaccharide sequence for binding AT
- Predictable dose response in most cases so does not require monitoring (cf UFH)
Describe the effect of unfractionated heparin on APTT
Describe the effect of LMWH on APTT
How does warfarin work?
Warfarin blocks the recycling of Vit K.
It is a vitamin K antagonist (competes with Vit K) that works by interfering with protein (gamma) carboxylation.
It therefore reduces synthesis of functional factors II, VII, IX and X by the liver, inducing an anticoagulated state slowly.
Why does warfarin administration require monitoring?
- Narrow therapeutic index
- Many dietary, physiological and drug interactions
How are the effects of warfarin reversed?
- Reversed slowly by Vit K administration: takes several hours to work
- Reversed rapidly by infusion of coagulation factors:
- PCC
- FFP
Describe the depletion of coagulation factors upon warfarin administration
What are the side-effects of warfarin?
- Bleeding
- Minor 5%pa
- Major 0.9-3.0%pa
- Fatal 0.25%pa
- Skin necrosis
- Purple toe syndrome
- Embryopathy: chondrodysplasia punctata
What is skin necrosis?
Severe protein C deficiency
- 2-3 days after starting Warfarin
- Thrombosis predominantly in adipose tissues
What is purple toe syndrome?
Disrupted atheromatous plaques bleed
- Cholesterol emboli lodge in extremities